Hydromorphone Hydrochloride
Total Payments
$76,797
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $38,399 | 1 | 0 |
| 2021 | $38,399 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $76,797 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Bedford NEMA Support | Hikma Pharmaceuticals USA | $76,797 | 0 |
Top Doctors Receiving Payments for Hydromorphone Hydrochloride
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bonita Springs, FL | $76,797 | 2 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $76,797
Product Information
- Type Drug
- Total Payments $76,797
- Total Doctors 0
- Transactions 2
About Hydromorphone Hydrochloride
Hydromorphone Hydrochloride is a drug associated with $76,797 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2021 to 2022. In 2022, $38,399 was paid across 1 transactions to 0 doctors.
The most common payment nature for Hydromorphone Hydrochloride is "Unspecified" ($76,797, 100.0% of total).
Hydromorphone Hydrochloride is associated with 1 research study, including "Bedford NEMA Support" ($76,797).